American Macular Degeneration Foundation (AMDF) is a non-profit organization focused on providing information and support for individuals affected by Age-related Macular Degeneration (AMD) while also funding research for its treatments.

American Macular Degeneration Foundation (AMDF)

Doheny Eye Institute focuses on the conservation, improvement, and restoration of human eyesight, according to self-described mission.

Doheny Eye Institute

Macular Society | 2,683 followers on LinkedIn. Beating the fear and isolation of macular disease with world-class research, and the best advice and support. | The Macular Society is the leading charity in the UK supporting people with macular disease, the biggest cause of sight loss in the UK. Our vision is to Beat Macular Disease and our mission is to beat the fear and isolation of macular disease by funding world-class research and providing the best advice and support. Together, we will Beat Macular Disease.

Nigel Gorvett

Board Member | Biotech-Pharma Executive | Independent Consultant | Global Product Development _ Strategic Planning _ Program & Project…

Walter Low, PhD

Head of Partnerships at Macular Society

Sarah Jarman

Regional Manager - Central Region at Macular Society

Paul Holden

Macular Society

Like many boys his age, 11-year-old Freddie Tennant is enthralled by his Xbox, playing it when he gets in from school. But while many parents might roll their eyes at their child being so glued to their technology, Freddie's mother, Stacy, encourages him. 'There's so much else he can't do and this brings him joy,' she says.

A recent survey of over 2,000 UK adults found that half of people expect to experience some form of sight loss within the next decade, yet more than a quarter do not have regular eye tests. Conducted by Apellis Pharmaceuticals , the survey aimed to understand public attitudes and perceptions about sight loss. The findings revealed that 90% of people consider sight their most valued sense. Among those surveyed, 53% expect to face sight loss in the next ten years, with this expectation rising to 59% among people over 50. The survey also showed that many people underestimate how common sight loss is. Half of the respondents thought that fewer than one million people in the UK are affected, but the real number is twice that. Alarmingly, over a quarter of people said they did not have regular eye exams, and 34% would delay seeking medical help for more than a month if they experienced vision problems. The survey also found that more than half of the participants believe it would be challenging to prevent sight loss in those over 70. Our chief executive, Ed Holloway , says: "The fact that so many people worry about and fear sight loss highlights that more needs to be done to increase awareness of eye health and the importance of regular eye checks." Read more here: https://lnkd.in/eGqE_Kyn

We’re very grateful to #MacuSaveGold and OcuPlan who are kindly sponsoring our Macular Disease Conference: Hope for the Future, which returns this weekend. From 9.15am-4pm this Saturday, 14 September we’ll hear from the macular disease experts, such as Doctor Jamie Ellingford and Professor Ian Pearce , and you’ll have a chance to put your questions to them live. The online talks will be split between two virtual rooms – inherited retinal disease and age-related macular degeneration – allowing you to dip in and out of the talks, depending on your interest. We’ll be diving into the latest trials and breakthroughs, dietary and nutritional advice and what's on the horizon. From Stargardt disease advancements to the potential of a new dry AMD treatment in the UK, there will be something for everyone. For the full timetables, head to https://lnkd.in/ed9AZVFk - please note times are approximate and subject to change. You can register in advance or simply head to www.macularsociety.org on Saturday, where the link for the conference will go live at 9am. The phone line will also go live at this time. Register for the 2024 Macular Disease Conference: https://lnkd.in/eFaZMSMW Whether you’re joining us by computer, tablet, smartphone or dialing in by phone, we’re really looking forward to welcoming you!

Our phone lines will be down for a few hours this morning (from 10am) as we transition to a more accessible system. During this time you won’t be able to reach us via phone. However, we will still respond to your emails at help@macularsociety.org Phone services will be back online after 2pm. We apologise in advance for any inconvenience and thank you for your patience and understanding.

🔬 How do our genes influence macular disease and how close are we to treating dry age-related macular degeneration (AMD) and Stargardt disease in the UK? These are just some of the topics experts will be discussing at this year’s Macular Disease Conference ‘Hope for the Future’ on Saturday 14 September. Among the many researchers joining the event will be Doctor Jamie Ellingford , who will lead an update on The Manchester Eye Tissue Repository Genome-Transcriptome Project and how genetic changes can lead to macular disease in some people. Others include Professor Ian Pearce who will discuss the new treatments for AMD currently being considered for approval in UK and Europe. Professor Jane Sowden and Owen Jones will also provide an update on research into the use of stem cell-derived photoreceptors for macular repair. From groundbreaking research updates, to diet and nutrition advice and tips for everyday living, there will be something for everyone. And, if you know someone newly diagnosed with macular disease, there is a specially tailored programme to support them and their loved ones too. The free conference will be held online once again, so you can easily switch between sessions. Every talk will also be available to watch on demand after the event. Register now to secure your place at: https://lnkd.in/eFaZMSMW We look forward to seeing you in September! The Macular Disease Conference 2024 'Hope for the Future' is kindly sponsored by #MacuSaveGold and OcuPlan .

A patient advisory group is needed for a Moorfields Eye Charity study looking at the effectiveness, safety and fairness of AI-based eye image testing. Complete the form below if you're interested in the future of AI and how macular conditions are diagnosed. The recruitment deadline is Tuesday, 30 July. Apply below 👇 https://lnkd.in/ejzcgRar

For more than 13 years, Jane has navigated the ups and downs of life with macular disease. In a new series of short films, she is one of three volunteers who has bravely shared her experiences, to help anyone facing a similar diagnosis. Jane talks about the impact of being told she was losing her sight: “One of my children had a congenital heart disease and had major heart surgery when she was ten months old, and my husband collapsed and died when he was 55 and this has had as much impact on my life as those two events.” Jane goes on to share her advice for coping with the impact of macular disease: “My biggest tip for coping with emotional difficulties taking on board macular degeneration is to talk to somebody about it. The Macular Society run a very good counselling service and they listen to what you’re saying about how you’re coping with your disease and the frustrations that you’re feeling. It’s really, really vital to know that there is somebody out there that can support you through this really difficult journey.” To hear more from Jane and how she continues to stay positive, watch the first film in our Living with Macular Disease series.

We're delighted to announce the appointment of our new chief executive. Ed Holloway will join the Macular Society in July, helping to lead us in our mission to Beat Macular Disease. Holloway brings with him a wealth of experience in the charity sector, having served as chief executive of the Bank Workers Society for two years and previously working for the MS Society for 14 years, where he led the transformation of their services to the MS community. In his new role, Holloway succeeds Cathy Yelf, who has led the Macular Society since 2015. With a career spanning over two decades in health and wellbeing charities, Holloway is driven by his passion for the role that charities play in transforming the lives of people affected by health conditions. Reflecting on his appointment, he says: “The Macular Society is an inspiring organisation serving a vital cause, and I look forward to using my experience in the sector to lead the organisation as it continues its essential work.” He recognises the need for advancements in macular disease treatment: "It is such an important cause. With nearly 1.5m people affected in the UK we urgently need to see more progress in research and for macular disease to be given the priority it deserves. He adds: “The organisation's clearly in a really strong position and I hope I can build on its successes and help to make progress towards beating macular disease.” We extend our heartfelt gratitude to Cathy Yelf for her years of dedicated service. Cathy says: “I am delighted Ed is joining the Society and I know it will continue to thrive and flourish under his leadership.” As we welcome Ed, we are excited about the future and the continued growth and impact of the Macular Society.

On behalf of the UK Ageing Research Funders' Forum (UKARFF), we've created a short survey to better understand researchers' training needs. If you can spare a couple of minutes, you can complete it here: tinyurl.com/4ptbhtya The survey closes on 20th May.

The Dunhill Medical Trust

Applications for our 2025 London Marathon places are now open! Do something amazing in 2025 and apply to join #TeamMacular at the iconic TCS London Marathon. Run for Macular Society to Beat Macular Disease! Places are very limited, so please apply as soon as possible - https://lnkd.in/dsbXhj5U If you are a visually impaired runner, London Marathon Events can offer a free guide/support runner place. If you would like further details, please get in touch by emailing community@macularsociety.org

Metric
Company Name	American Macular Degeneration Foundation (AMDF)	Doheny Eye Institute
Symbol
MSH ID	ORG:MACULAR	ORG:DOHENY
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Non-profit Organization	Medical Research
Country	US	US
Stage
Employee Count
Website	macular.org	doheny.org
LinkedIn	macular-disease-society	doheny-eye-institute
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	48.42K	3.63K
Web Traffic Growth	0.33	0.22
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

MACU

ORG:MACULAR

American Macular Degeneration Foundation (AMDF)

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue